Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iNDX.Ai is a private healthcare informatics and bioinformatics company focused on AI-enabled biomarker discovery and translational research for biotech and pharmaceutical customers. The company provides a cloud-based software platform, centered on iCore, to integrate, manage, analyze, and interrogate multi-omics, clinical, and biospecimen data used in precision medicine studies and biomarker-rich clinical trials. Its product suite also includes tools such as iTracker, iQuery, iDiscovery, and the integrated correlation engine (iCE) for specimen management, deep data interrogation, and analytics. iNDX.Ai appears to be oriented primarily toward oncology and immuno-oncology use cases rather than developing proprietary therapeutics. The company is based in Cupertino, California and operates as an active private business serving life science research and clinical development workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iNDX.Ai.